UK markets open in 2 hours 38 minutes
NIKKEI 225
39,105.28 +488.18 (+1.26%) HANG SENG
18,930.02 -265.58 (-1.38%) CRUDE OIL
77.09 -0.48 (-0.62%) GOLD FUTURES
2,374.40 -18.50 (-0.77%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,520.33 -350.66 (-0.64%)
Fresenius Medical Care AG (0H9X.IL)
IOB - IOB Delayed price. Currency in EUR
Add to watchlist
At close: 05:32PM BST
| Previous close | 39.42 |
| Open | 0.00 |
| Bid | 38.41 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 158,180 |
| Market cap | 14.085B |
| Beta (5Y monthly) | 0.91 |
| PE ratio (TTM) | 19.17 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.12 (3.38%) |
| Ex-dividend date | 17 May 2023 |
| 1y target est | N/A |
- PR Newswire
Fresenius Medical Care showcases leadership and innovation in kidney care disease at 61st European Renal Association (ERA) Congress 2024
Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced the presentation of nearly 40 company-affiliated research abstracts at the 61st European Renal Association (ERA) Congress, taking place May 23-26, 2024, in Stockholm, Sweden and virtually.
- PR Newswire
Fresenius Medical Care Annual General Meeting: Company makes significant progress in its Transformation Efforts and confirms its ambitious 2024 Growth Targets
Fresenius Medical Care (FME), the global leader in providing products and services for people with kidney diseases, is executing its strategic turnaround plan and is well on track to achieve its goals for 2024.
- PR Newswire
Fresenius Medical Care starts the year with strong earnings growth
Helen Giza, Chief Executive Officer of Fresenius Medical Care, said:
© 2024 Yahoo. All rights reserved.